SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

Marrone Bio Innovations Q1 EPS $(0.050) Misses $(0.030) Estimate, Sales $9.650M Miss $10.110M Estimate

Marrone Bio Innovations (NASDAQ:MBII) reported quarterly losses of $(0.050) per share which missed the analyst consensus estimate of $(0.030) by 66.67 percent. This is a 25 percent decrease over losses of $(0.040) per

Benzinga · 05/11/2020 20:29

Marrone Bio Innovations (NASDAQ:MBII) reported quarterly losses of $(0.050) per share which missed the analyst consensus estimate of $(0.030) by 66.67 percent. This is a 25 percent decrease over losses of $(0.040) per share from the same period last year. The company reported quarterly sales of $9.650 million which missed the analyst consensus estimate of $10.110 million by 4.55 percent. This is a 10.72 percent increase over sales of $8.716 million the same period last year.